Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 16.29
+0.29 (1.81%)
Apr 30, 2026, 3:00 PM CST
SHA:600521 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 227.33 | 1,119 | 830.47 | 1,168 | 487.54 |
Depreciation & Amortization | 1,011 | 903.9 | 780.37 | 672.01 | 563.07 |
Other Amortization | 13.24 | 28.68 | 9.25 | 7.08 | 2.45 |
Loss (Gain) From Sale of Assets | -0 | -2.33 | 0.29 | -3.59 | -0.6 |
Asset Writedown & Restructuring Costs | 170.22 | 30.13 | 39.41 | 21.69 | 10.35 |
Loss (Gain) From Sale of Investments | -20.71 | 97.72 | 161.97 | 66.48 | -442.95 |
Provision & Write-off of Bad Debts | - | 36.58 | -7.93 | 45.37 | 14.73 |
Other Operating Activities | 258.26 | 229.27 | 241.69 | 86.91 | 220.3 |
Change in Accounts Receivable | -126.34 | -786.09 | 269.5 | -818.89 | -388.87 |
Change in Inventory | -471.61 | -78.33 | -140.05 | -679.92 | -386.81 |
Change in Accounts Payable | 165.02 | 597.68 | 19.99 | 669.89 | 679.92 |
Change in Other Net Operating Assets | 8.31 | 14.14 | -0.49 | 81.61 | 113.74 |
Operating Cash Flow | 1,230 | 2,173 | 2,217 | 1,243 | 938.43 |
Operating Cash Flow Growth | -43.38% | -2.00% | 78.41% | 32.42% | -39.67% |
Capital Expenditures | -1,966 | -1,853 | -1,592 | -2,316 | -2,434 |
Sale of Property, Plant & Equipment | 9.95 | 5.2 | 4.84 | 10.72 | 9.94 |
Investment in Securities | 86.27 | -72.57 | -18.7 | -106.66 | 58.19 |
Other Investing Activities | 2.28 | 0.43 | -16.53 | -20.35 | 9.48 |
Investing Cash Flow | -1,868 | -1,920 | -1,623 | -2,433 | -2,357 |
Long-Term Debt Issued | 4,726 | 6,202 | 3,321 | 3,873 | 3,238 |
Long-Term Debt Repaid | -4,304 | -5,637 | -3,321 | -2,732 | -1,931 |
Net Debt Issued (Repaid) | 421.99 | 564.79 | -0.6 | 1,140 | 1,307 |
Issuance of Common Stock | 591.52 | - | - | 37.68 | 371.82 |
Repurchase of Common Stock | - | -189.92 | -71 | -172.43 | -150.01 |
Common Dividends Paid | -546.18 | -475.36 | -556.01 | -318.32 | -387.21 |
Other Financing Activities | 149.75 | -32.42 | -16.63 | -78.36 | -23.31 |
Financing Cash Flow | 617.07 | -132.91 | -644.23 | 609.04 | 1,118 |
Foreign Exchange Rate Adjustments | -10.65 | 51.16 | 29 | 54.65 | -43.49 |
Net Cash Flow | -31.05 | 170.63 | -20.98 | -526.18 | -343.57 |
Free Cash Flow | -735.96 | 319.33 | 624.63 | -1,074 | -1,496 |
Free Cash Flow Growth | - | -48.88% | - | - | - |
Free Cash Flow Margin | -8.57% | 3.35% | 7.52% | -12.99% | -22.52% |
Free Cash Flow Per Share | -0.50 | 0.22 | 0.43 | -0.73 | -1.04 |
Cash Interest Paid | - | 0.06 | 0.06 | 0.06 | 0.06 |
Cash Income Tax Paid | 391.44 | 568.31 | 614.3 | 206.43 | 227.84 |
Levered Free Cash Flow | -613.38 | -474.18 | 15.26 | -1,715 | -1,721 |
Unlevered Free Cash Flow | -613.38 | -336.8 | 160.07 | -1,578 | -1,617 |
Change in Working Capital | -429.72 | -270.27 | 161.5 | -821.02 | 83.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.